Tim Watts, CFO at Shield Therapeutics #STX presenting at our Life Sciences Investor Briefing Watch Now
The FTSE 250 is comprised of mid-capitalised companies, not covered by the FTSE 100 and represents approximately 15% of UK market capitalisation.
|FTSE 250 Value||20,169.4|
|52 Week High||20,606.15|
|52 Week Low||17,054.72|